Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antidiabetic heterocyclic compounds

Antidiabetic heterocyclic compounds

US Patent 11072602 · Granted Jul 27, 2021

Estimated economic value: $304,446,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists2025
NK3 modulators and uses thereof2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
GPR40 agonists2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024
Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024
AMPK activators2023
Bicycloheptane pyrrolidine orexin receptor agonists2023
GPR119 agonists2022